Kuehn Law Investigates Arcus Biosciences Officers and Directors for Potential Self-Dealing

GlobeNewswire··Read original
2▲0 ▼1Impact / 5
Summary · why it matters

Kuehn Law is investigating whether certain officers and directors of Arcus Biosciences breached their fiduciary duties to shareholders. The shareholder litigation firm is examining potential self-dealing, and shareholders may be entitled to damages and corporate governance reforms. Long-term stockholders are encouraged to contact the firm for a free consultation with no obligation.

Impact on assets 1

Biotech & Genomic Medicine▼ · 1 stocks
© 2026 MarketIVNews